Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
INVESTING
iShares Silver Trust, Virgin Galactic, Viela Bio: 5 Stock Gainers for Monday
By Rob Lenihan
Feb 1, 2021 4:30 PM EST
INVESTING
iShares Silver Trust, Virgin Galactic, Viela Bio: 5 Stock Gainers for Monday
By Rob Lenihan
Feb 1, 2021 4:30 PM EST
PRESS RELEASES
SHAREHOLDER ALERT: WeissLaw LLP Investigates Viela Bio, Inc.
By PR Newswire
Feb 1, 2021 3:12 PM EST
INVESTING
Viela Bio Spikes as Horizon Therapeutics Agrees to Acquire It for $3.5 Billion
By Vidhi Choudhary
Feb 1, 2021 10:21 AM EST
PRESS RELEASES
(VIE Alert) Johnson Fistel Investigates Proposed Sale Of Viela Bio; Are Shareholders Getting A Fair Deal?
By PR Newswire
Feb 1, 2021 9:36 AM EST
PRESS RELEASES
Horizon Therapeutics Plc Announces Short-Term TEPEZZA® (teprotumumab-trbw) Supply Disruption Due To Government-Mandated (Operation Warp Speed) COVID-19 Vaccine Production
By Business Wire
Dec 17, 2020 6:40 AM EST
PRESS RELEASES
Horizon Therapeutics Plc Provides $1 Million In Scholarships To Help Economically Disadvantaged Students And Students Of Color Further Their Liberal Arts And Health Professions Education
By Business Wire
Dec 3, 2020 9:00 AM EST
PRESS RELEASES
Great Place To Work Names Horizon Therapeutics Plc To Best Workplaces For Parents List
By Business Wire
Dec 2, 2020 9:15 AM EST
PRESS RELEASES
Horizon Therapeutics Plc Donates Additional $1.2 Million To Support COVID-19 Relief Efforts In Illinois And Other Impacted U.S. And International Communities
By Business Wire
Nov 30, 2020 8:00 AM EST
PRESS RELEASES
Horizon Therapeutics Plc To Participate In Upcoming Investor Conferences
By Business Wire
Nov 25, 2020 8:00 AM EST
PRESS RELEASES
Horizon Therapeutics Plc And Halozyme Therapeutics, Inc. Enter Global Collaboration And License Agreement For ENHANZE® Technology
By Business Wire
Nov 23, 2020 8:00 AM EST
PRESS RELEASES
Horizon Therapeutics Plc And Halozyme Therapeutics, Inc. Enter Global Collaboration And License Agreement For ENHANZE® Technology
By PR Newswire
Nov 23, 2020 8:00 AM EST
PRESS RELEASES
First Thyroid Eye Disease (TED) Awareness Week To Increase Education And Understanding Of Vision-Threatening Disease
By Business Wire
Nov 16, 2020 8:00 AM EST
PRESS RELEASES
New Data Build On Growing Evidence Supporting TEPEZZA® (teprotumumab-trbw) Efficacy In Thyroid Eye Disease (TED), Including In Patients With Less Severe Disease And Longer Disease Duration
By Business Wire
Nov 13, 2020 8:30 AM EST
PRESS RELEASES
Horizon Therapeutics Plc CEO Tim Walbert Honored With RARE Champion Award At Global Genes Champions Of Hope Gala
By Business Wire
Nov 13, 2020 8:00 AM EST
PRESS RELEASES
Horizon Therapeutics Plc To Participate In Upcoming Investor Conferences
By Business Wire
Nov 12, 2020 8:00 AM EST
PRESS RELEASES
Higher Response Rates In RECIPE Randomized Controlled Trial Of KRYSTEXXA® (pegloticase Injection) Concomitantly Used With The Immunomodulator Mycophenolate Mofetil
By Business Wire
Nov 2, 2020 2:00 PM EST
PRESS RELEASES
Karin Rosén, M.D., Ph.D. (Photo: Business Wire)
By Business Wire
Nov 2, 2020 6:58 AM EST
PRESS RELEASES
Chicago Tribune Names Horizon Therapeutics A 2020 Top Workplace For The Sixth Consecutive Year
By Business Wire
Oct 30, 2020 9:15 AM EDT
PRESS RELEASES
New TEPEZZA® (teprotumumab-trbw) Data To Be Presented At The American Academy Of Ophthalmology 2020 Annual Meeting
By Business Wire
Oct 30, 2020 8:00 AM EDT
PRESS RELEASES
AGC Biologics And Horizon Therapeutics Plc Expand Partnership
By PR Newswire
Oct 29, 2020 3:00 PM EDT
PRESS RELEASES
Horizon Therapeutics Plc Initiates Clinical Trial To Assess Shorter Infusion Duration For KRYSTEXXA® (pegloticase Injection) Concomitantly Used With Methotrexate To Treat Uncontrolled Gout
By Business Wire
Oct 29, 2020 8:00 AM EDT
PRESS RELEASES
Horizon Therapeutics Plc Named One Of The Most Innovative Companies By Crain's Chicago Business
By Business Wire
Oct 26, 2020 8:00 AM EDT
PRESS RELEASES
Horizon Therapeutics Plc Named One Of The Best Adoption-Friendly Workplaces By The Dave Thomas Foundation For Adoption
By Business Wire
Oct 23, 2020 8:00 AM EDT
PRESS RELEASES
New Data Offers Insights On Treatment With KRYSTEXXA® (pegloticase Injection) Among Kidney Transplant Patients For The Management Of Uncontrolled Gout
By Business Wire
Oct 22, 2020 10:00 AM EDT
